Virus injection targets liver tumors in early trial
Disease control
Completed
This early-phase study tested a new treatment called JX-594, a modified virus injected directly into liver tumors. The main goal was to find a safe dose and check for side effects in 14 patients with advanced liver cancer that had not responded to standard treatments. The study f…
Phase: PHASE1 • Sponsor: Jennerex Biotherapeutics • Aim: Disease control
Last updated May 26, 2026 12:00 UTC